日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Corrigendum: Mathematical modeling in autoimmune diseases: from theory to clinical application

更正：自身免疫性疾病的数学建模：从理论到临床应用

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1557929
Ugolkov, Yaroslav; Nikitich, Antonina; Leon, Cristina; Helmlinger, Gabriel; Peskov, Kirill; Sokolov, Victor; Volkova, Alina
自身免疫性疾病
免疫/内分泌
发表日期：2025
文献求助 收藏

Exposure-Response Relationships for Axatilimab in Patients with Chronic Graft-Versus-Host Disease

阿沙替利单抗治疗慢性移植物抗宿主病患者的暴露-反应关系

期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.3731
Yang, Yan-Ou; Volkova, Alina; Sokolov, Victor; Liu, Xing; Leon, Cristina; Kosinsky, Yuri; Sheng, Jennifer; Chen, Xuejun
发表日期：2025
文献求助 收藏

Semimechanistic Population PK/PD Modeling of Axatilimab in Healthy Participants and Patients With Solid Tumors or Chronic Graft-Versus-Host Disease.

对健康受试者和实体瘤或慢性移植物抗宿主病患者进行阿沙替利单抗的半机制群体药代动力学/药效动力学建模

期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.3503
Yang Yan-Ou, Sokolov Victor, Volkova Alina, Liu Xing, Leon Cristina, Kosinsky Yuri, Barker Breann, Zhang Xuecheng, Ordentlich Peter, Sheng Jennifer, Chen Xuejun
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

An Integrative Mechanistic Model of Type 1 IFN-Mediated Inflammation in Systemic Lupus Erythematosus

系统性红斑狼疮中 I 型干扰素介导炎症的整合机制模型

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.70043
Volkova, Alina; Sokolov, Victor; Tettamanti, Florencia; Verma, Meghna; Ugolkov, Yaroslav; Peskov, Kirill; Tang, Weifeng; Kimko, Holly
炎症
炎症/感染
Immunology/Inflammation
红斑狼疮
免疫/内分泌
发表日期：2025
文献求助 收藏

Mathematical modeling in autoimmune diseases: from theory to clinical application

自身免疫性疾病的数学建模：从理论到临床应用

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1371620
Ugolkov, Yaroslav; Nikitich, Antonina; Leon, Cristina; Helmlinger, Gabriel; Peskov, Kirill; Sokolov, Victor; Volkova, Alina
免疫/内分泌
自身免疫性疾病
发表日期：2024
文献求助 收藏

A tutorial for model-based evaluation and translation of cardiovascular safety in preclinical trials

心血管安全性临床前试验中基于模型的评估和转化教程

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.13082
Kulesh, Victoria; Vasyutin, Igor; Volkova, Alina; Peskov, Kirill; Kimko, Holly; Sokolov, Victor; Alluri, Ravindra
发表日期：2024
文献求助 收藏

Biocompatible Phosphorescent O(2) Sensors Based on Ir(III) Complexes for In Vivo Hypoxia Imaging

基于Ir(III)配合物的生物相容性磷光O(2)传感器用于体内缺氧成像

期刊:Biosensors-Basel
影响因子:5.6
doi:10.3390/bios13070680
Samandarsangari, Mozhgan; Kozina, Daria O; Sokolov, Victor V; Komarova, Anastasia D; Shirmanova, Marina V; Kritchenkov, Ilya S; Tunik, Sergey P
发表日期：2023
文献求助 收藏

Effectiveness of dapagliflozin as an insulin adjunct in type 1 diabetes: a semi-mechanistic exposure-response model

达格列净作为胰岛素辅助药物治疗1型糖尿病的疗效：半机制暴露-反应模型

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2023.1229255
Sokolov, Victor; Yakovleva, Tatiana; Penland, Robert C; Boulton, David W; Tang, Weifeng
代谢
糖尿病
免疫/内分泌
发表日期：2023
文献求助 收藏

A mechanistic modeling platform of SGLT2 inhibition: Implications for type 1 diabetes

SGLT2抑制的机制建模平台：对1型糖尿病的启示

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.12956
Sokolov, Victor; Yakovleva, Tatiana; Stolbov, Leonid; Penland, Robert C; Boulton, David; Parkinson, Joanna; Tang, Weifeng
SGLT2
糖尿病
代谢
发表日期：2023
文献求助 收藏

Optimization of the MACE endpoint composition to increase power in studies of lipid-lowering therapies-a model-based meta-analysis

优化MACE终点构成以提高降脂疗法研究的统计效力——基于模型的荟萃分析

期刊:Frontiers in Cardiovascular Medicine
影响因子:2.9
doi:10.3389/fcvm.2023.1242845
Volkova, Alina; Shulgin, Boris; Helmlinger, Gabriel; Peskov, Kirill; Sokolov, Victor
发表日期：2023
文献求助 收藏